Related topics: women , vaccine , journal of the national cancer institute , human papillomavirus , hpv
Cervical cancer
hideCervical cancer is malignant cancer of the cervix uteri or cervical area. It may present with vaginal bleeding but symptoms may be absent until the cancer is in its advanced stages. Treatment consists of surgery (including local excision) in early stages and chemotherapy and radiotherapy in advanced stages of the disease.
Pap smear screening can identify potentially precancerous changes. Treatment of high grade changes can prevent the development of cancer. In developed countries, the widespread use of cervical screening programs has reduced the incidence of invasive cervical cancer by 50% or more.[citation needed]
Human papillomavirus (HPV) infection is a necessary factor in the development of nearly all cases of cervical cancer. HPV vaccine effective against the two strains of HPV that cause the most cervical cancer has been licensed in the U.S. and the EU. These two HPV strains together are currently responsible for approximately 70% of all cervical cancers. Since the vaccine only covers some high-risk types, women should seek regular Pap smear screening, even after vaccination.
For more information about Cervical cancer, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
News tagged with cervical cancer
Papillomavirus silences innate immune response
Dec 03, 2009 |
4 / 5 (1) |
1
In the 1980s, Harald zur Hausen and his co-workers discovered that specific types of human papillomavirus (HPV) cause cervical cancer. Scientists soon found out how these pathogens cause cells to degenerate. ...
Report: 20-somethings can go 2 years between Paps
Nov 20, 2009 |
not rated yet |
0
(AP) -- Most women in their 20s can have a Pap smear every two years instead of annually, say new guidelines that conclude that's enough to catch slow-growing cervical cancer.
Genetic changes shown to be important indicators for disease progression in cervical cancer patients
Nov 13, 2009 |
not rated yet |
0
Cervical cancer patients with specific changes in the cancer genome have a three- or fourfold increased risk of relapse after standard treatment compared to patients without these changes, according to a study by Norwegian ...
Age-specific evaluation of HPV DNA testing vs. cytology screening
Nov 10, 2009 |
not rated yet |
0
Human papillomavirus (HPV) DNA testing with cytology triage is more sensitive than conventional cytology screening for detecting cervical lesions, according to a new study published online November 9 in the Journal of th ...
FDA-approved drugs eliminate, prevent cervical cancer in mice
Nov 09, 2009 |
not rated yet |
0
Researchers at the University of Wisconsin-Madison School of Medicine and Public Health have eliminated cervical cancer in mice with two FDA-approved drugs currently used to treat breast cancer and osteoporosis.
One disease, not one demographic
Oct 30, 2009 |
5 / 5 (1) |
0
The Asian continent has nearly four billion people living in 47 different countries, and each of these groups has their own unique set of health issues. But when they come to the United States, they're often lumped into one ...
Alternative to pap test does not appear to be better for detecting cervical cancer
Oct 27, 2009 |
not rated yet |
0
A Dutch study that included nearly 90,000 women finds that liquid-based cytology, a commonly used alternative to conventional Pap tests, is not superior to Pap tests for the detection of cervical cancer precursors or cancer, ...
Panel backs vaccine as cervical cancer alternative
Medicine & Health / Medications
Oct 21, 2009 |
not rated yet |
0
(AP) -- A second kind of vaccine against cervical cancer may be added to the recommended list for girls and young women after a federal advisory panel voted Wednesday to support it.
Scientists identify common HPV genotypes in northern India, encourage vaccination
Oct 11, 2009 |
5 / 5 (1) |
0
Although a wide spectrum of human papillomavirus is seen across the population of India, HPV-16 and HPV-18 are the most common types and a vaccination targeting these types could eliminate 75 percent of the cervical cancers ...
Vaccinating boys against human papillomavirus not cost-effective
Oct 09, 2009 |
not rated yet |
1
Persistent infection with high-risk types of human papillomavirus (HPV), a sexually transmitted virus, is known to be a cause of cervical cancer. Current guidelines prioritize HPV vaccination of pre-adolescent girls, which ...
UK official: Vaccine unlikely to have caused death
Medicine & Health / Medications
Sep 29, 2009 |
3 / 5 (2) |
0
(AP) -- A British health official said Tuesday that the sudden death of 14-year-old girl was very unlikely to have been caused by the vaccine she was given hours before she died.
British girl dies after cervical cancer vaccine jab
Medicine & Health / Medications
Sep 29, 2009 |
1 / 5 (2) |
3
British drug giant GlaxoSmithKline said Tuesday it was working with health authorities here probing the death of a schoolgirl following a cervical cancer vaccination.
Precancer? Earliest cancer? Milk-duct cells vexing
Sep 24, 2009 |
not rated yet |
0
(AP) -- Some doctors tell patients they have "stage zero" breast cancer. Others call it a precancer.
Prostate cancer may be caused by virus, study indicates
Sep 18, 2009 |
4.7 / 5 (11) |
0
Mounting evidence indicates that prostate cancer is an infectious disease caused by a recently identified virus.
CDC: 1 in 3 teen girls got cervical cancer vaccine
Medicine & Health / Medications
Sep 17, 2009 |
not rated yet |
0
(AP) -- A new government report shows one in three teenage girls have rolled up their sleeves for a relatively new vaccine against cervical cancer, but vaccination rates vary dramatically between states.
